Human Tumor Sequencing Project

NCT01608230 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 35

Last updated 2014-11-18

No results posted yet for this study

Summary

This study is being done to learn more about genetic mutations in cancer cells and to find out how the development of new technologies can increase knowledge of these mutations and possibly predict an individual's response to certain treatments.

Conditions

Sponsors & Collaborators

  • Scripps Translational Science Institute

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2014-04-30
Completion
2014-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01608230 on ClinicalTrials.gov